Sort
48,018 grants matching “immunotherapy”
Targeting UHRF1 in combinational immunotherapy
$461,025Xiao-Fan Wang · Duke University · R01 · FY2023 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$460,981Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2024 · CA
Identifying Chemo-Neoepitopes for Immunotherapy Interventions Against Triple-Negative Breast Cancer
$460,977Yurij Ionov · Roswell Park Cancer Institute Corp · R21 · FY2024 · CA
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeuticnanoparticles for TB
$460,961Jessica L Reynolds · State University Of New York At Buffalo · R01 · FY2021 · AI
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$460,943Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Tumor Immune MicroEnvironment Facility
$460,935Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$460,837Duane A. Mitchell · University Of Florida · R01 · FY2015 · CA
Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer
$460,829Jeremy Borniger · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$460,800William E Fisher · Baylor College Of Medicine · U01 · FY2024 · DK
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$460,749Shruthi Naik · Mayo Clinic Rochester · U01 · FY2025 · CA
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
$460,692Guizhi Zhu · Virginia Commonwealth University · R01 · FY2022 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$460,674Judith A. Varner · University Of California, San Diego · R01 · FY2019 · CA
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
$460,640Xiaobo Zhou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$460,631Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
A new approach to immunotherapy for ALS
$460,625Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · NS
T Cell Homeostasis
$460,612Stephen C Jameson · University Of Minnesota · R01 · FY2023 · AI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$460,517Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AR
Vaccines for the Treatment of Opiate Addiction
$460,508Kim D Janda · Scripps Research Institute, The · R01 · FY2011 · DA
Vaccines for the Treatment of Opiate Addiction
$460,508Kim D Janda · Scripps Research Institute, The · R01 · FY2012 · DA
Vaccines for the Treatment of Opiate Addiction
$460,508Kim D Janda · Scripps Research Institute, The · R01 · FY2014 · DA
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
$460,426Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA
CANCER METASTASIS--BIOLOGY AND TREATMENT
$460,348University Of Texas Md Anderson Can Ctr · R35 · FY2000 · CA
UCLA Tumor Immunology Institutional Training Grant
$460,343Michael A Teitell · University Of California Los Angeles · T32 · FY2023 · CA
Senescence as a Therapeutic Endpoint
$460,322Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$460,310Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA